Browsing by Author Chung, HC

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 6 of 6
TitleAuthor(s)Issue DateViews
 
Characterization of cues from natural multi-species biofilms that induce larval attachment of the polychaete Hydroides elegans
Journal:Aquatic Biology
Hung, OSLee, OOThiyagarajan, VHe, HPXu, YChung, HCQiu, JWQian, PY
2008
156
 
Interim report for a phase II, multi-centre, dose-escalating study of LB80380/ANA380 in hepatitis B patients with lamivudine-resistant YMDD mutant HBV
Proceeding/Conference:Journal of Hepatology
Lai, CLHan, KHYoon, SKUM, SHYuen, MFKim, HSKim, HRChung, HCKim, CRHsyu, PAverett, DKim, J
2005
155
 
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
Journal:The Lancet
Shitara, KOzguroglu, MBang, Y-JBartolmeo, MDMandala, MRyu, M-HFornaro, LOlesinski, TCaglevic, CChung, HCMuro, KGoekkurt, EMansoor, WMcDermott, RSShacham-Shumueli, EChen, XMayo, CKang, SPOhtsu, AFuchs, CSKEYNOTE-061 investigatorsLam, KO
2018
35
 
Phase II multi-centre, dose-escalating study of LB80380 (ANA380) in hepatitis B patients with lamivudine-resistant YMDD mutant HBV
Proceeding/Conference:Journal of Hepatology
Lai, CLHan, KHYoon, SKUm, SHYuen, MFKim, HSKim, HRChung, HCKim, CRHsyu, PAverett, DWorland, SKim, J
2006
226
 
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study
Journal:European Journal of Cancer
Chau, IPeck-Radosavljevic, MBorg, CMalfertheiner, PSeitz, JFPark, JORyoo, BYYen, CJKudo, MPoon, RTPPastorelli, DBlanc, JFChung, HCBaron, ADOkusaka, TBowman, LCui, ZLGirvan, ACAbada, PBYang, LZhu, AX
2017
53
 
Statutory rights and de facto constitutional supremacy in Hong Kong?
Proceeding/Conference:International Journal of Constitutional Law
Yap, PJChung, HC
2019
45
Showing results 1 to 6 of 6